DIVIDEND ANNOUNCEMENT: General Contingent Value Rt/Ligand Pharmaceuticals Inc (OTCBB:LGNYZ) on 06/16/2026 declared a dividend of $0.0025 per share

General Contingent Value Rt/Ligand Pharmaceuticals Inc (OTCBB:LGNYZ) on 06/16/2026 declared a dividend of $ 0.0025 per share payable on July 01, 2026 to shareholders of record as of June 26, 2026. Dividend amount recorded is an increase of $ 0.0017 from last dividend Paid.

General Contingent Value Rt/Ligand Pharmaceuticals Inc (OTCBB:LGNYZ) has paid dividends since 2012, has a current dividend yield of 0.0000000000% and has increased its dividends for 0 successive years.

The stock price closed yesterday at $ 0.04 and has a 52 week low/high of $ 0.01 and $ 0.09.

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of medicines. Co. does this by providing financing, licensing its technologies or both. Its Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. This technology has enabled several U.S. Food and Drug Administration (FDA)-approved products, including Gilead's Veklury, Amgen's Kyprolis, Baxter International's Nexterone, Melinta Therapeutics' Baxdela and Sage Therapeutics' Zulresso.

For more information on General Contingent Value Rt/Ligand Pharmaceuticals Inc click here.